<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><description>米内网是中国领先的集医药健康产业研究、医院市场研究、零售市场研究、商业渠道研究、互联网在线医药健康信息服务于一体的综合性专业信息服务平台。目前拥有七项数据分析技术获国家专利，每月收集数据3000多万条，有63个专业数据库为医药健康行业服务。</description><managingEditor> (hellodword)</managingEditor><pubDate>Fri, 26 Feb 2021 20:46:32 +0800</pubDate><image><url>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</url><title>米内网 | wechat-feeds</title><link>http://MjM5NzQ4MTg2MQ.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>80个新药燃爆4000亿中成药市场！独家产品年年暴涨，康缘、天士力1类新药来了</title><link>https://mp.weixin.qq.com/s/z6FjI-fRaT4Rnc6IJQMP9w</link><description></description><content:encoded><![CDATA[80个新药燃爆4000亿中成药市场！独家产品年年暴涨，康缘、天士力1类新药来了]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>【重磅】恒瑞领军地位遇危机！科伦入局暴涨150%的抗血栓注射剂</title><link>https://mp.weixin.qq.com/s/iaEf0rvusbbYY-U9y-OSQQ</link><description></description><content:encoded><![CDATA[【重磅】恒瑞领军地位遇危机！科伦入局暴涨150%的抗血栓注射剂]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>【瞩目】东阳光药猛攻70亿胰岛素大品种，甘李国产独家将被打破</title><link>https://mp.weixin.qq.com/s/aGslgmspJJm7RZQ6vMb81g</link><description></description><content:encoded><![CDATA[【瞩目】东阳光药猛攻70亿胰岛素大品种，甘李国产独家将被打破]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>【焦点】10亿止痛大品种恩华获批了！原研九成市场节节败退</title><link>https://mp.weixin.qq.com/s/H55GnEClKOBI82RrqRsJ7w</link><description></description><content:encoded><![CDATA[【焦点】10亿止痛大品种恩华获批了！原研九成市场节节败退]]></content:encoded><pubDate>Fri, 26 Feb 2021 17:09:44 +0800</pubDate></item><item><title>奥赛康发威了！11个品种抢首仿，7款创新药亮相，首家过评率超60%</title><link>https://mp.weixin.qq.com/s/GZY41hg9woavu3IIMAHqeQ</link><description></description><content:encoded><![CDATA[奥赛康发威了！11个品种抢首仿，7款创新药亮相，首家过评率超60%]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>【瞩目】扬子江18个注射剂领跑过评榜，将拿下30亿大品种</title><link>https://mp.weixin.qq.com/s/FVQWVXznvwZYH2nRLlKnpA</link><description></description><content:encoded><![CDATA[【瞩目】扬子江18个注射剂领跑过评榜，将拿下30亿大品种]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>【聚焦】人福今年首个ANDA获批，国内30亿市场暂无首仿</title><link>https://mp.weixin.qq.com/s/e8GS-ZLCCnid8cjLG6_xHw</link><description></description><content:encoded><![CDATA[【聚焦】人福今年首个ANDA获批，国内30亿市场暂无首仿]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>【关注】重磅儿童药，这家四川药企拿下首仿后过评</title><link>https://mp.weixin.qq.com/s/JllXFwiC5lLclpDKZ5xrIQ</link><description></description><content:encoded><![CDATA[【关注】重磅儿童药，这家四川药企拿下首仿后过评]]></content:encoded><pubDate>Thu, 25 Feb 2021 16:00:27 +0800</pubDate></item><item><title>241家药企2020成绩单出炉！12家净利润超20亿，以岭、大参林……突破10亿，这16家首亏</title><link>https://mp.weixin.qq.com/s/nzSUwx7sA0ha8_kLKYA2kA</link><description></description><content:encoded><![CDATA[241家药企2020成绩单出炉！12家净利润超20亿，以岭、大参林……突破10亿，这16家首亏]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>【获批】10亿注射剂激战！齐鲁、海思科同日过评</title><link>https://mp.weixin.qq.com/s/X0yE0i6E9A6c0nwmQdqpLw</link><description></description><content:encoded><![CDATA[【获批】10亿注射剂激战！齐鲁、海思科同日过评]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>【审评】扬子江、恒瑞……围攻30亿注射剂！石四药也来了</title><link>https://mp.weixin.qq.com/s/5ZVWU-AILMEaohSE4SkThQ</link><description></description><content:encoded><![CDATA[【审评】扬子江、恒瑞……围攻30亿注射剂！石四药也来了]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>【关注】暴涨200%！石药“瞄准”抗肿瘤药，原研药再受冲击</title><link>https://mp.weixin.qq.com/s/1vNUMZcxKnnj903fmbJMgg</link><description></description><content:encoded><![CDATA[【关注】暴涨200%！石药“瞄准”抗肿瘤药，原研药再受冲击]]></content:encoded><pubDate>Wed, 24 Feb 2021 17:02:51 +0800</pubDate></item><item><title>齐鲁“猛攻”创新药！15款1类新药在研，$2.35亿引进抗癌药，23个集采品种助力创新</title><link>https://mp.weixin.qq.com/s/uVSKF9dkWY5SXnCMyUeO1A</link><description></description><content:encoded><![CDATA[齐鲁“猛攻”创新药！15款1类新药在研，$2.35亿引进抗癌药，23个集采品种助力创新]]></content:encoded><pubDate>Tue, 23 Feb 2021 16:18:25 +0800</pubDate></item><item><title>【瞩目】汇宇制药将拿下$5亿抗肿瘤注射剂</title><link>https://mp.weixin.qq.com/s/n5n5wEb2Rhah8hp7tLO1CA</link><description></description><content:encoded><![CDATA[【瞩目】汇宇制药将拿下$5亿抗肿瘤注射剂]]></content:encoded><pubDate>Tue, 23 Feb 2021 16:18:25 +0800</pubDate></item><item><title>【重磅】奥赛康抢首仿，瞄准暴涨800%的ALK抑制剂</title><link>https://mp.weixin.qq.com/s/N9mi64x7jJf2pcv37eJMTg</link><description></description><content:encoded><![CDATA[【重磅】奥赛康抢首仿，瞄准暴涨800%的ALK抑制剂]]></content:encoded><pubDate>Tue, 23 Feb 2021 16:18:25 +0800</pubDate></item><item><title>【市场】超20亿抗ED药，又一家药企入局</title><link>https://mp.weixin.qq.com/s/d5LXHYiG2mQN3FnE_kj47g</link><description></description><content:encoded><![CDATA[【市场】超20亿抗ED药，又一家药企入局]]></content:encoded><pubDate>Tue, 23 Feb 2021 16:18:25 +0800</pubDate></item><item><title>东阳光药逆势爆发！4大产品轻松赚下1.3亿，6款新药“搅局”3大千亿市场</title><link>https://mp.weixin.qq.com/s/QssAkqN96jgFZ0bJFpVk-w</link><description></description><content:encoded><![CDATA[东阳光药逆势爆发！4大产品轻松赚下1.3亿，6款新药“搅局”3大千亿市场]]></content:encoded><pubDate>Mon, 22 Feb 2021 16:28:18 +0800</pubDate></item><item><title>【重磅】上市一年暴涨300%，扬子江冲击这个神经药物首仿</title><link>https://mp.weixin.qq.com/s/JaCPo-MVX7T4h6EUU5_iEA</link><description></description><content:encoded><![CDATA[【重磅】上市一年暴涨300%，扬子江冲击这个神经药物首仿]]></content:encoded><pubDate>Mon, 22 Feb 2021 16:28:18 +0800</pubDate></item><item><title>【瞩目】倍特进军造影剂市场！首个目标是拜耳超10亿品种</title><link>https://mp.weixin.qq.com/s/TL3ZBSp47SlapiDaH9rW1g</link><description></description><content:encoded><![CDATA[【瞩目】倍特进军造影剂市场！首个目标是拜耳超10亿品种]]></content:encoded><pubDate>Mon, 22 Feb 2021 16:28:18 +0800</pubDate></item><item><title>【火爆】苑东注射新品来袭！这个独家产品近亿市场将被打破</title><link>https://mp.weixin.qq.com/s/TtHzsVnx4Pb_HztpEq4WJg</link><description></description><content:encoded><![CDATA[【火爆】苑东注射新品来袭！这个独家产品近亿市场将被打破]]></content:encoded><pubDate>Mon, 22 Feb 2021 16:28:18 +0800</pubDate></item></channel></rss>